ProAir® Digihaler®
Sponsors
Teva Branded Pharmaceutical Products R&D LLC
Conditions
Asthma
Phase 3
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed--Dose Combination on Severe Asthma Exacerbations in Patients with Asthma
RecruitingCTIS2023-505435-12-00
Start: 2024-06-04Target: 770Updated: 2025-12-18
A 4-Week, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Trial of Fluticasone Propionate/Albuterol Sulfate Combination compared to Fluticasone Propionate, Albuterol Sulfate or Placebo delivered by Multidose Dry Powder Inhaler in Participants 12 Years and Older with Asthma
RecruitingCTIS2024-517991-39-00
Start: 2025-07-22Target: 555Updated: 2026-01-12